Trial Profile
Assessment of a single intravenous (IV) iron therapy versus oral iron in the management of preoperative anaemia patients undergoing elective surgery at the Launceston General Hospital (LGH).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferrous sulfate (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 15 Jul 2015 New trial record
- 14 Jun 2015 Primary endpoint has been met. (To assess the efficacy of oral iron versus IV iron in preoperative anaemia setting)
- 14 Jun 2015 Status changed from recruiting to completed as per abstract presented in 20th Congress of the European Haematology Association.